首页> 外文期刊>QJM >Use of biomarkers or echocardiography in pulmonary embolism: the Swiss Venous Thromboembolism Registry
【24h】

Use of biomarkers or echocardiography in pulmonary embolism: the Swiss Venous Thromboembolism Registry

机译:在肺栓塞中使用生物标志物或超声心动图:瑞士静脉血栓栓塞登记处

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Cardiac biomarkers and echocardiography for assessing right ventricular function are recommended to risk stratify patients with acute non-massive pulmonary embolism (PE), but it remains unclear if these tests are performed systematically in daily practice.
机译:背景:建议使用心脏生物标志物和超声心动图评估右心室功能,以对急性非大规模肺栓塞(PE)患者进行危险分层,但是尚不清楚这些检查是否在日常实践中系统地进行。

著录项

  • 来源
    《QJM》 |2012年第12期|p.1163-1169|共7页
  • 作者单位

    From the 1Medical Department, Sanofi-Aventis (Suisse) SA, Meyrin 1217, Switzerland, 2Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College School of Medicine, Charing Cross Hospital, London W6 8RF, UK, 3Division of General Internal Medicine, University Hospital, Bern 3010, 4Clinic of Angiology, University Hospital, Zurich 8091, 5Department of Internal Medicine, Cantonal Hospital, Fribourg 1708, 6Department of Internal Medicine, University Hospital, Basel 4031 and 7Division of Vascular Medicine, Swiss Cardiovascular Center, University Hospital, Bern 3010, Switzerland;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 01:06:58

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号